TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Patients without thromboembolic or bleeding complications
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of MYD88 L265P mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Prevalence of CXCR4 Whim-like mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Urine Albumin to Creatinine Ratio (UACR) Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change on the Social Phobia Inventory (SPIN)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change of the autoregulation index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline of High sensitivity C-Reactive Protein (hsCRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention rate of dexamethasone induced hiccup
Endpoint domain: Adverse events/effects
Primary endpoint: Mean attack frequency (MAF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in gambling expenditure
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Presence of delayed bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Achievement of Physical Activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Rate of change of bone mineral density (BMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of change of calcium and bone profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Catheter related bladder discomfort (CRBD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prolonged All Tobacco Abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Breast Cosmetic Outcome
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: percentage of trial subjects with COVID-19
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Substance P and ACh vasodilatation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Accuracy in diagnosing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with Related Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in female genital tract maraviroc concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportions of endothelial progenitor cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of detected csPCa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percent reduction in nutritional anemia among mothers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent reduction in nutritional anemia in infants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Participants Who Experienced a Decrease in Pn-BHR Area Under the Curve (AUC) of > 80% Compared With Baseline Values Before Week 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percent Change in Peanut Specific Immunoglobulin E (IgE) From Baseline to After Pn-BHR Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Peanut Specific Immunoglobulin E (IgE) After Pn-BHR Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: volume of osteonecrotic lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dorsomedial Prefrontal Cortex Activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction in Anxiety Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: incidence of falling at home
Endpoint domain: Adverse events/effects
Primary endpoint: admission in nursing home
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Area under the glucose infusion rate curve from 0-24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Blood measures of inflammation and muscle damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bacteremic rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Treatment Failure (Intubation or Death)
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants With Intubation
Endpoint domain: Mortality/survival
Primary endpoint: Time to obtain heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First atrial fibrillation episode
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Superficial and/or deep postoperative infection rate
Endpoint domain: Adverse events/effects
Primary endpoint: Peri-operative hemorrhage
Endpoint domain: Adverse events/effects
Primary endpoint: Change in child literacy
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in caregiver involvement
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in the NIH-CPSI total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eradication Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Prevalence of sleep disordered breathing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Participants With Early Onset Primary Adverse Events (PAEs): Death
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Early Onset PAEs: Myocardial Infarction, Cardiac Tamponade/Perforation, Thromboembolism, Stroke/Cerebrovascular Accident, Transient Ischemic Attack, Phrenic Nerve Paralysis, and Major Vascular Access Complication/Bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Acute Procedural Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Disease-Control rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Occurrence of limiting toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Cardiac telemetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to Achieve Patient Stabilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Groningen Radiotherapy-Induced Xerostomia (GRIX) Sticky Saliva Total Score AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of peripheral artery disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevalence of glucometabolic disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: use of antibiotic treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lean Body Mass measured by DEXA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annual Rate of Serious Bacterial Infections
Endpoint domain: Adverse events/effects
Primary endpoint: Annual Rate of All Infections
Endpoint domain: Adverse events/effects
Primary endpoint: Trough Levels of IgG Maintained During the Study Period in Relation to Dose Frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Average Daily Opioid Use (MME)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of geophagia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Vanderbilt ADHD Rating Scale scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Step Length Variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prostatic Carcinoma Proliferation Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Clinically Significant Portal Hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: No-Show Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Hematological Response of the Erythropoetic System
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Medical Outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psychological Outcomes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of patients experiencing discontinuations due to adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Performance of the HHM system response to meal insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of Participants With at Least 1 Treatment Emergent Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: IBS activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Macro and micro structural properties of grey matter and white matter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival Free of Neurological Progression
Endpoint domain: Mortality/survival
Primary endpoint: Time to treatment failure (TTF) of palbociclib in combination with endocrine therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TTF of subsequent therapy after end of palbociclib treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Capillary glycaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Combined infectious morbidity
Endpoint domain: Adverse events/effects
Primary endpoint: Rates of percutaneous coronary intervention (PCI) outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time taken to carry out each local anaesthetic block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Area under the plasma concentration-time profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Euroscore II overall predictive power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Euroscore II predictive power for surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Euroscore II predictive power for transcatheter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Visual acuity testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stereoacuity testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vergence system testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in COSS-P total T-scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Plaque amount
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical success (resolution of patient signs and symptoms)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased Minute Ventilation (MV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Decreased Average Minute Ventilation (MV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total intelligence quotient
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of anaphylactic reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Hypersensitivity Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Time to achieve readiness to discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Numeric Rating Score for pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Financial Well-being
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: First Adjudicated Serious Fall-Related Injury
Endpoint domain: Adverse events/effects
Primary endpoint: Assessment of 12-lead digital electrocardiograms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Device Placement Success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to placement of device
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rate after FOLFIRI reintroduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Air leak time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Curve of Infliximab Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with protective antibody response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Frontal Plane Knee Projection Angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Subject Confidence in Sports Safety and Performance Perceptions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intrauterine displacement of the IUD
Endpoint domain: Adverse events/effects
Primary endpoint: Glycaemic parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Neonatal Admission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute change of OCD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in upper limb motor blocks duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceptual Threshold of Touch
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Plasma Concentration at Steady State (Cmax,ss)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration Curve at Steady State (AUC24, ss)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time for the onset of sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with positive patch test reactions to cosmetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CA-125 response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child Mortality Rate
Endpoint domain: Mortality/survival
Primary endpoint: Specified clinical outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee position sense
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival of transferred cells
Endpoint domain: Mortality/survival
Primary endpoint: Neuromuscular Recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Low frequency resistance R5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response of viral load to retreatment after interruption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in protein expression of myogenin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change from baseline in maximum cystometric capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: rate of early discharge
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Variance between urine and oral fluid riboflavin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery rate from fever at Day 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Titre of Streptococcus mutans
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percentages of non-dippers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Individuation Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fugl-Meyer (Motor Function - Upper Extremity Subscale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Electromyographic activity of sternocleidomastoid muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Who Achieved a Clinical Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Subjects Reported With Unsolicited Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in function of the transplanted facial segment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in function of the upper extremity transplant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of HIV-infected pregnant women on ART with HIV VL test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of HIV-uninfected women with repeat antenatal HIV test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Suppression and Emergence of Resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean Time to Onset of Sensory and Motor Block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Duration of Sensory and/or Motor Block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Baroreflex Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 3-year Overall survival
Endpoint domain: Mortality/survival
Primary endpoint: Difference in TAHC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects with any adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in symptoms of inattention and overactivity/impulsivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of gefitinib administration
Endpoint domain: Adverse events/effects
Primary endpoint: Radiological outcomes (X-ray, CT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of Inhibitor Development
Endpoint domain: Adverse events/effects
Primary endpoint: Muscle function assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Expiratory Airflow Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Maximum Airway Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage Change in Mean Maximal Quadriceps Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percentage Change in Mean Voluntary Quadriceps Activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percentage Change in Mean Knee Flexion Angle During Walking Gait
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Primary treatment duration
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Fasting serum LDL cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Repeated fatal or non fatal suicidal act
Endpoint domain: Mortality/survival
Primary endpoint: Change in diastolic dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Quick Disability of the Arm, Shoulder and Hand (QuickDASH)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Clinician rated Yale Brown Obsessive Compulsive Scale (Y-BOCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-time Curve of Ethinylestradiol in Plasma (AUC0-24,ss)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Device functionality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anti-PLAC1 autoantibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Acute toxicity during radiotherapy
Endpoint domain: Adverse events/effects
Primary endpoint: Number of primary care appointments kept
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change in plasma nitrite concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in the motor part of the Fugl-Meyer Assessment of the Upper Extremity (FMA-UE) scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alzheimer's Disease Assessment Scale-cognition (ADAS-cog)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Detection sensitivity of recurrence sites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antibody status in HCW
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes